Each week, we feature a physician executive. This week's featured physician executive is Robert Temple, MD. Dr. Temple is the Deputy Director, Clinical Science, Center for Drug Evaluation & Research at the FDA.
How did he get there?
Dr. Temple received a B.A. Magna cum Laude from Harvard College in 1963 and received the M.D. degree from New York University School of Medicine in 1967. At NYU he was elected to Alpha Omega Alpha. He completed an internship and residency in internal medicine at the Columbia Presbyterian Medical Center in 1969. He is board-certified in internal medicine and clinical pharmacology. Dr. Temple was in the Clinical Endocrinology Branch of the National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health from 1969-1972.
He became a reviewing Medical Officer in the Division of Metabolic and Endocrine Drug Products in 1972, and moved to become Assistant to the Director of the Bureau of Drugs in 1974. In 1976, he became the Director of the Division of Cardio-Renal Drug Products, serving in that role until 1982. From 1982 to 1988 he was Acting Director and then Director of the Office of Drug Research and Review. The responsibilities of that office have been divided in various ways among five Offices of Drug Evaluation (ODE's 1-5). Among other awards, he has received FDA's Award of Merit on six occasions, three Commissioner's Special Citations, the Public Health Service Superior Service Award, the DHHS Distinguished Service Award, the Secretary's Special Citation, and the Drug Information Association Outstanding Service Award. He received the American Society for Clinical Pharmacology and Therapeutics' Rawls-Palmer Progress in Medicine Lecture and Award in 2001. He also received the National Organization for Rare Disorders Public Health Leadership Award in 2001. In 2002, he received FDLI's Distinguished Service and Leadership Award. In 2005, he received the Drug Information Association Distinguished Career Award.